Related references
Note: Only part of the references are listed.Personalizing therapy for multidrug resistant TB: the potential of Rapid Whole Genome Sequencing
Josephine M. Bryant et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement
J. Dominguez et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study
Louise J. Pankhurst et al.
LANCET RESPIRATORY MEDICINE (2016)
Early insights into the potential of the Oxford Nanopore MinION for the detection of antimicrobial resistance genes
Kim Judge et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Clinical Application of Whole-Genome Sequencing To Inform Treatment for Multidrug-Resistant Tuberculosis Cases
Adam A. Witney et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples
Amanda C. Brown et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data
Silke Feuerriegel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
Timothy M. Walker et al.
LANCET INFECTIOUS DISEASES (2015)
Detection of Drug-Resistant Tuberculosis by Xpert MTB/RIF in Swaziland
Elisabeth Sanchez-Padilla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis
Phelim Bradley et al.
NATURE COMMUNICATIONS (2015)
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Francesc Coll et al.
GENOME MEDICINE (2015)
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Christoph Lange et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Profiling of rpoB Mutations and MICs for Rifampin and Rifabutin in Mycobacterium tuberculosis
F. B. Jamieson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
A defining decade in DNA sequencing
John D. McPherson
NATURE METHODS (2014)
Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis
Yu Pang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Benchmarking short sequence mapping tools
Ayat Hatem et al.
BMC BIOINFORMATICS (2013)
Rapid Whole-Genome Sequencing for Investigation of a Suspected Tuberculosis Outbreak
M. Estee Toeroek et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
Timothy M. Walker et al.
LANCET INFECTIOUS DISEASES (2013)
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance
Hongtai Zhang et al.
NATURE GENETICS (2013)
Whole-Genome Sequencing for Rapid Susceptibility Testing of M-tuberculosis
Claudio U. Koeser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
Frederick A. Sirgel et al.
PLOS ONE (2013)
First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries
Doris Hillemann et al.
PLOS ONE (2013)
Single nucleotide polymorphisms in Mycobacterium tuberculosis and the need for a curated database
David Stucki et al.
TUBERCULOSIS (2013)
New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
Seidu Malik et al.
PLOS ONE (2012)
Treatment Outcomes of Isoniazid-Resistant Tuberculosis Patients, Western Cape Province, South Africa
Karen R. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2011)
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice
Ann Sturdy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis
Gilman Kit Hang Siu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak
Jennifer L. Gardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Danica Helb et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens
Doris Hillemann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Tuberculosis Drug Resistance Mutation Database
Andreas Sandgren et al.
PLOS MEDICINE (2009)
XDR-TB genome sequencing: a glimpse of the microbiology of the future
N. J. Loman et al.
FUTURE MICROBIOLOGY (2008)
Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis
Philip Supply et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Rationale and uses of a public HIV drug-resistance database
Robert W. Shafer
JOURNAL OF INFECTIOUS DISEASES (2006)
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates
D Hillemann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Share Paper
